(2259 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Environment and Immunology StandUp TalksSpeakers ...
-
Phenotypes and Endotypes
-
Delabelling adults
-
Exercise-induced urticaria and anaphylaxis
-
Viral infection and asthma
-
Updates in [severe] asthma in adults
-
Danger signs
-
New perspectives for anaphylaxis
-
Asthma: phenotypes to endotypes
-
Tackling anaphylaxis
-
Phenotypes and endotypes of occupational allergy
-
Differential diagnosis
-
Exercise: induced asthma and rhinitis
-
Preparing a grant: Dos and Don'ts
-
Developing an adolescent and young adult allergy service
-
Current and future perspectives
-
An update on food allergy
-
Vaccines for older adults: benefits and limitations
-
Big data and cluster analysis: a real life perspective
-
Bronchiectasis and severe asthma
-
Launch of the Biological guidelines
-
Elevated tryptase – Now what?
-
Severe Asthma and COVID-19
-
Is anaphylaxis really rare in children?
-
Big Data Analysis: MetabolomicsView Presentation
-
Eosinophilic fasciitis, an unusual presentation
-
What’s different about the adolescent brain?
-
The basics of severe asthma - biomarkers
-
Allergy to Kale
-
The clinical clues and pitfalls in contact dermatitis
-
Microbiota in immune-based therapies
-
Telemedicine and Tele-health
-
Neuroimmunology and allergy
-
Asma e alergia em Angola
-
Asma e alergia em pandemia
-
Electronic Health in Severe Asthma
-
Psychological support to peanut allergic children and their families
-
Risk assessment and active management of food allergy
-
Desensitization in chemotherapy and biologics
-
Airborne enzymes – New and re-emerging occupational hazards
-
Non-T2 directed biologicals
-
A system biology and machine learning approach to childhood asthma
-
Late onset T2 asthma – a case study
-
Epithelial cell barrier and allergic diseases
-
Air pollution and allergy: call for action!
-
AI models
-
New and clinically relevant contact allergens
-
Anti IL4/13 and IL33/TSLP
-
Therapies for multiple-tree nut allergies
-
Lung function testing
-
Hypersensitivity to antiepileptic drugs
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Management of adverse reactions to biologics
-
Cellular tests for the diagnosing and monitoring of allergy
-
Understanding parent preferences for paediatric allergy services
-
Immune responses in desentitization and tolerance
-
Hologenome and obesity
-
Hand eczema during the COVID-19 pandemic
-
Living with food allergy
-
Is IgA a piece of the EoE puzzle?
-
Novel pharamacological targets
-
Precision Medicine and AIT
-
Wild-fires, pollution, climate change and other threats
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Food industry perspective
-
Probiotics and prebiotics: an on-going journey
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Covid 19 and air pollution: is there a relationship?
-
Anaphylaxis in ICD-11
-
Inflammatory biomarkers
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Precision medicine and biomarkers of atopic dermatitis
-
An update on prevention of allergic diseases
-
Update on drug allergy
-
Update of the WAO anaphylaxis guidance
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Sustained unresponsiveness to tree nuts after low dose oral immunotherapy in children aged 9-24 months
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Elderly asthma
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
Tezepelumab (anti-TSLP) in asthma
-
Diagnosis of insect venom allergy: back to basics
-
Difficult to control asthma in children
-
Insight from translational research on oral tolerance induction through breast milk
-
Role Viral reactivations
-
How to select and follow a biological for asthma and CRSwNP
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Implementation of telehealth in asthma management: trials and tribulations
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Primary care in CRDs during COVID
-
Asthma management during the COVID-19 pandemics
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Potential biomarkers for diagnosis and treatment for CSU
-
Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
Hypereosinophilic syndromes and autoimmunity
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Immune modulation in local allergic rhinitis
-
Environmental epigenomics of allergy
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Chronic rhinosinusitis with nasal polyps
-
A patient with an acute reaction: recognize, document and treat
-
Assessment of adherence to treatment using mHealth
-
Impaired olfaction: diagnostics and its role in diseases
-
What do we learn from subgroup analyses in phase-III trials?
-
Difficult to control asthma in adults
-
AIT, Biologicals and Covid vaccination
-
Can we prevent the development of food allergy?
-
Immune response to Corona virus infection
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Endotype-driven treatment in chronic rhinosinusitis
-
How to keep a child with anaphylaxis safe in school
-
Social media and Allergies: how can we support our patients?
-
Current status on prophylaxis in HAE
-
Big changes in asthma treatment : GINA 2019
-
AIT in the pediatric population
-
Predicting adverse reactions to biologicals
-
Lesson learned from the pathogenesis of SARS-COV2
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Moisturisers for the primary prevention of food allergy
-
Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis
-
Over-the-counter allergy prevention weaning products
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
Does human milk and its composition matter for development and prevention of allergies?
-
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
-
Food allergy - the beginners guide
-
Route of exposure determines the immune response to food allergens
-
Alternative free-from foods to reach a balanced diet
-
Prevention and therapy in primary immunodeficiencies: Vaccination
-
Structural biology of food allergens and cross reactivity
-
Virtual care, social media and mHealth for allergy management
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
It looks like urticaria – but is it?
-
Focus on Patient. Personalised therapy for severe asthma
-
May contain traces… management in children with food allergies
-
GINA Guidelines Update
-
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
-
Mechanisms of non IgE mediated food allergy
-
New insights in urticaria mechanisms
-
How can we improve the quality of life of patients with severe food allergy?
-
E-cigarettes: mechanistic link to lung injury
-
Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard
-
Immunotherapy in severe asthma (AIT)
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Role of antigen-presenting cells in tolerance and allergy
-
Molecular and structural considerations for aerosolization of food allergens
-
How to improve outcomes
-
Recognizing immediate reactions in contact dermatitis
-
Sleep patterns and development of children with atopic dermatitis
-
Impact of climate change on the immune system
-
Impact of climate change on asthma exacerbations
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
Food allergy: new allergens on the block
-
Autoimmunity in atopic diseases
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
How do allergens sensitize?
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
The ‘allergy tool kit’ for the transition clinic
-
Linking bovine milk components and their possible association with allergic diseases
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Integrated systems biology strategies for diagnostics and immune monitoring in allergy
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Covid-19 in "Allergy" journal
-
Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps
-
The dilemma of food allergy additives
-
Innate trained immunity: An evolutionary perspective
-
The role of infection in chronic spontaneous urticaria
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
Immunological basis of food aversion
-
We are what we eat - importance of food to health, moving past simple calories
-
Should we do patch testing in children with eczema?
-
Urban green spaces - The exposure and allergenicity index
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
Early life wheeze - risk factors for asthma in school age
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
Allergen immunotherapy for food allergy
-
Unusual presentations of contact dermatitis
-
Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
The underlying immunology of pruritus
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
-
Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Are drug provocation tests required before decision to desensitize?
-
Proton pump inhibitor responsive esophageal eosinophilia is this EoE or not EoE (Pro & Con Session: Con)
-
Proton pump inhibitor responsive esophageal eosinophilia is this EoE or not EoE (Pro & Con Session: Pro)
-
Bronchial allergen challenge in research
-
Can group consultations work in allergy? Learning from rheumatology
-
Prevention of food allergy: where are we now?
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
Ligelizumab (anti-IgE) in chronic spontaneous urticaria
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
What is the immunological basis for new biologicals?
-
Development of a childhood asthma prediction model using machine learning approaches
-
Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Skin care from birth for allergy prevention: results today
-
Occupational respiratory allergy in food processing industries
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
Siblings and atopy by living standard, period, and atopy assessment method: a systematic review and meta-analysis
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids
-
A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
-
Using the “atopic dermatitis yardstick” in clinical practice
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Novel therapeutic approaches targeting endotypes of severe airway disease
-
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
-
Plans of GARD in terms of surveillance after COVID
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma
-
Value of c-kit mutations in the skin, peripheral blood and bone marrow in pediatric mastocytosis. What does it tell us?
-
Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
Outcome measures for adult’s vs children in the clinic during allergen immunotherapy
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
Do adrenaline auto-injectors save lives?
-
Tree nut allergy: path from national to global data
-
Implementing component resolved diagnostics in allergy diagnosis
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Evidence of immunotherapy on allergy prevention?
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Targeted approaches for asthma
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
How to evaluate lung function? Hands-on plus lecture
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study
-
Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs – is it useful?
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Vaccines- Is this the tool to end the pandemic?
-
AAAAI Practice Parameters
-
Mental health needs and access to care among patients with food allergy
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis
-
Impacting quality of life with PALFORZIA
-
Characterization of the immunological properties of different β-glucans on myeloid dendritic cells
-
FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
EAACI Guidelines on environmental health
-
Food elimination diet in eosinophilic esophagitis and other eosinophilic gastrointestinal disorders (Clinical cases)
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow’s milk allergy
-
Gut microbiome - based therapeutic approaches
-
Baseline demographics and disease characteristics of patients with eosinophilic esophagitis in part A of the 3-part, randomized, placebo-controlled, phase 3 TREET study
-
Novel insight into development of allergic diseases
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Assessing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) severity by JESREC algorithm
-
Placebo effects is an integrated part of the treatment benefits of AIT (Pro & Con Session: Pro)
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Novel cell based assays in allergy diagnostics
-
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
Should blood eosinophils tresholds guide patient selection for anti-IL5 biologicals? (Pro&Con Session: Pro)
-
B cells in in chronic rhinosinusitis: friend or foe
-
When hives are not chronic urticaria
-
Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study
-
MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
-
BAT in clinical practice. Is it possible?
-
The ABC of pollen food syndrome (PFS) & Lipid transfer protein (LTP): nutritional issues of fruit and vegetable allergy
-
Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
-
Dysregulated regulation of skin structure and barrier function by insufficient IL-37 in allergic inflammation of atopic dermatitis
-
Influence of antigen density and TLR ligands on efficacy of a VLP-based vaccine against Peanut Allergy: mechanistic insights
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
Human and computational models of immune mediated inflammatory skin disease: challenges, insights and perspectives
-
Early biomarkers for severe drug hypersensitivity reactions
-
Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy
-
The impact of the exposome on allergies and asthma – a global view on urbanisation, climate change and pollution
-
House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
The engineering-medicine interface
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
The expression of inflammatory mediators in macrophages, epithelium and dendritic cells after urban particulate matter stimulation in triple co-culture scheme
-
Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Extreme prematurity strongly imprints circulating Natural Killer- and ?? T cells, which are further influenced by sepsis
-
Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
Nasal allergen challenge
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Biotin interference can cause false-negative IgE test results in patients with anaphylaxis
-
How to use social media in your professional practice: the clinician perspective
-
Weak correlation between percentage of predicted values of PEF and FEV1 parameters in children population
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
Dupilumab (anti-IL4Ra) in CRSwNP
-
Fast acting disruptive IgE inhibitors rapidly desensitize allergic effector cells and resolve IgE-mediated anaphylaxis
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE
-
Adherence: A challenge for Immunotherapy
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Bronchial allergen challenge in the clinic
-
Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis
-
Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project
-
Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg
-
Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Practical Course on Big data analysis: transcriptomics, metabolomics, CyTOF and flow cytometryView Presentation
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to beta-lactams using lymphocyte transformation test
-
Can the birch pollen be more aggressive in the polluted environments?
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment
-
Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
-
A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC)
-
The brain, nose, immune axis
-
Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
Show more Event Resources (344)Show Less-
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Peanut allergy and investigational DBV712: an updateIntroduction Antonella Muraro ...
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Severe type 2 asthma: phenotypes and precision treatment for patientsOpening remarks Stephanie Korn, Enrico Hef...
-
Reconsider the art of AITWelcome and introduction Pati...
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
Mite – the “diva” in AIT trialsWelcome and introduction Fill...
-
IgE in asthma and nasal polyposis: your questions answered
-
Patients with peanut allergy: the hope for a better life?Introduction Antonella Muraro ...
-
To eat or not to eat: that is the questionNutrition and gut health for prevention of food allergy ...
-
The Link between Early Diet and Food AllergyIntroduction Liam O’Mahony ...
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 InflammationOpening remarks Santiago Quirce ...
-
Chronic spontaneous urticaria: defining the pathway to successful managementWelcome and Introduction Marcus Maurer ...
-
Autoimmunity and immune deficits in IEI – uncovering APDSWelcome and Introduction Diag...
-
Treating peanut allergy with oral immunotherapy: new data and practical experienceIntroduction Jonathan O’B Hourihane ...
-
MicroCrystalline Tyrosine-associated allergoids: Reaching the top of the evidence pyramidRalph Mösges
-
Improving patients’ journeys in food allergyWelcome and introduction Alexandra Santos ...
-
A novel dual key solution to unlock the treatment of allergic rhinitisClinical challenges and management strategies in allergic rhinitis: where are we? ...
-
Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?Reflection on hereditary angioedema (HAE): Progress and perspectives ...
-
Re-thinking lung function testing in young children
-
Mind the PAF: a new route to managing chronic urticaria and allergic diseases?Welcome address Frank Siebenhaar ...
-
Mometasone furoate/ olopatadine: the value of novelty patient-centred careIntroduction and Patient Testimony ...
-
Pediatric Severe Asthma: Why Lung Function Matters
-
Advances in eosinophilic diseases
-
Biologics in CRSwNP: Comparative Efficacy and Real-World Effectiveness
-
Relegating OCS to last resort: Creating a paradigm shift in asthma managementAstraZeneca: Relegating OCS to last resort: Creating a paradigm shift in asthma management...
-
How can we improve the approach to treating chronic urticaria in children?Introduction Montserrat Alvaro Lozano ...
-
Type 2 Inflammation: What every clinician should knowHans In‘t Veen, Jasper Kappen This Company Sponsored Symposia...
-
A transformational approach to managing allergies to catsIntroduction Antonella Muraro ...
-
Latest real world data on the CMA journey; how can synbiotics reduce the health burden for infants and their families?Introduction Rosan Meyer ...
-
Efficacy and quality of life in HAE: The lanadelumab experience
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascadeIoana Agache, Andrew Menzies-gow, Stephanie Korn, Celeste Porsbjerg
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Exploring the Complexity of Chronic Spontaneous UrticariaChronic Spontaneous Urticaria (CSU): unpredictable, chronic and burdensome ...
-
Changing the way babies eat: Supporting early allergen feeding around the worldIntroduction Angela Claver Monzón ...
-
How do HMO modulate the immune system in infants with CMPA? emerging evidence and clinical implications.Introduction Clinical implica...
-
Everything you always wanted to know about SCIT but were afraid to askSCIT: Long-term efficacy Andrzej Bozek ...
-
Meet the experts on AIT in Food AllergyWelcome & Introduction Hans Van Schij...
-
Patients’ perspective : a must have for the future of Allergen ImmunotherapyIntroduction What can a patie...
-
Ameliorating atopy by targeted micronutrient supplementation with beta-lactoglobulinFranziska Roth-Walter
-
Navigating Type 2 Inflammation across the skin, airway, and esophagusNavigating Type 2 Inflammation across the skin, airway, and esophagus ...
Show more Sponsored Symposia (39)Show Less-
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. I
-
